• FDA QSR (21 CFR Part 820) / ISO 13485 gap assessment
  • Design controls review and documentation support
  • Establishment registration and device listing (21 CFR Part 807)
  • UDI system compliance review
  • Post-market surveillance plan development
  • Post-approval study (PAS) design for PMA holders
  • MDR (Medical Device Reporting) advisory: reportability determinations and 21 CFR Part 803 obligations